MRNA
Moderna, Inc.The S&P 500 ($745.76) is above its 10-day average ($739.38), so the market-trend check passes for every stock today, MRNA included. It flips market-wide if the index closes below $739.38.
MRNA's 50-day average has risen to $52.14, up from $49.73 10 sessions ago, so the long-term trend check passes. It would flip if that average stopped rising over its 10-session window.
MRNA hasn't touched its 21-day average ($59.34) in the last 3 sessions, so the pullback check fails. It passes on a dip back toward $59.34.
MRNA closed at $72.50, 11.1% above its 9-day average ($65.27) — short-term momentum is holding, so this check passes. It flips on a close below $65.27.
MRNA has 2 consecutive up-closes into today — at the limit of 2, so this check fails (the entry looks extended). It passes after a flat or down close resets the streak.
No high-volume gap-down consistent with an earnings miss has appeared in MRNA's last 30 sessions, so this check passes. It would flip if such a gap-down showed up inside that window.
MRNA has outpaced the S&P 500 by 60.4 percentage points over the last 20 sessions, so the relative-strength check passes. It flips if MRNA starts lagging the index over that window.
A stop at $57.90 is 20.1% below MRNA's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.
The stop sits 2.8× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.
Recent volume is 0.77× MRNA's 20-day average — below the 0.8× threshold, so the pullback looks quiet and this check passes. It flips if volume pushes past 0.8× that average.